FDA Panel Votes in Favor of Qnexa – MedPage Tomorrow
Los Angeles Times
FDA Panel Votes in Favor of Qnexa
MedPage Today
By Joyce Frieden, News Editor, MedPage Tomorrow SILVER SPRING, Md. – An FDA advisory panel has voted 20-2 to recommend approval of the weight-loss drug Qnexa, but urged the independent to require a post-approval trial to monitor for cardiovascular side effects …
Advisory Panel Favors Approval for Weight-Loss Drug
If Qnexa gets the hard light, who would get the drug?
FDA panel backs previously rejected obesity pill
Washington Post -Chicago Tribune
all 358 news articles »
Related posts:
- FDA panel backs previously rejected obesity pill – USA TOMORROW
- FDA Revokes Approval of Avastin for Breast Cancer – ABC News
- Citing Drug Resistance, US Restricts Less Antibiotics for Livestock – Latest York Times
- Orange Juice Tumbles Most in Two Years as ICE Boosts Margins – BusinessWeek
- Some former Komen supporters can’t forgive, forget – Nashville Tribune
Categorised as: hot babe